PRG4 and hepatocellular carcinoma: To explore the relationship between PRG4 and HCC cell sensitivity to chemotherapeutics in TACE, we measured the IC50 value of epirubicin in inhibiting HCC cells under different culture conditions with different PRG4 expression levels.